In a study published in the Proceedings of the National Academy of Sciences (Early Edition ahead of print), a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway…
Author: Medical News Today
Use Of Amniotic Membrane May Cause Complications In Strabismus Surgery
Postoperative adhesions are a major complication in strabismus surgery. Amniotic membrane has been used in the hopes of preventing these adhesions by forming a biological barrier during healing…
Partial Solar Eclipse Eye Safety Warning
When the partial solar eclipse occurs tomorrow morning, Tuesday 4 January, do not look directly at the sun or you risk permanently damaging your eyesight and even blindness, warns the UK government’s Interim Chief Medical Officer Dame Sally Davies…
Free Vision Screening Program Coming To Chicago, Miami, And San Antonio
The American Academy of Ophthalmology and its partners today announced the expansion of a new screening initiative, EyeSmart® EyeCheck, to combat undetected eye disease and visual impairment among at-risk populations in the United States. The free vi…
American Academy Of Ophthalmology Responds To Genentech Rebate Program For Lucentis Use
Genentech (Hoffman – La Roche) manufactures two critically important pharmaceuticals, Lucentis and Avastin, which are both used for treatment of several common eye diseases – including age-related macular degeneration (AMD)…
Iluvien For Diabetic Macular Edema Turned Down By FDA
Investigational drug Iluvien (fluocinolone acetonide intravitreal insert) for the treatment of diabetic macular edema cannot be approved in its present form, the FDA (Food and Drug Administration) wrote in its Complete Response Letter (CRL). Illuven is…
MCV Foundation To Receive $500,000 Research Donation
A new partnership between Richmond Eye & Ear Healthcare Alliance (REEHA) and the Medical College of Virginia Foundation will provide over $500,000 for the VCU Health System’s Department of Orthopaedics through December 2014…
Inspire Announces Launch Of DIQUASTM By Santen In Japan
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that DIQUASTM Ophthalmic Solution 3% (diquafosol tetrasodium) received pricing approval and was launched for sale today in Japan by its partner, Santen Pharmaceutical Co., Ltd. Inspire will receive…
American Academy Of Ophthalmology Joins Forces With Cloud Nine Development, LLC On The Eye Handbook IPhone Application
The American Academy of Ophthalmology (Academy) has collaborated with Cloud Nine Development, LLC, to enhance its free iPhone application, the Eye Handbook. The application, created for ophthalmologists by ophthalmologists, offers ophthalmic calculator…
One In Five Eyeglass Wearers Drives Without Prescription Glasses, Survey Reports
More than 90 percent of decisions and reactions made behind the wheel depend on good vision. While many believe a bright, sunny day is optimal for driving, the reality is that blinding glare from sun, snow and vehicles is a significant contributing fac…
Singapore Scientists First To Perform The Largest Genome-Wide Association Study On Central Corneal Thickness
A team of scientists from Singapore has discovered two genes from the collagen family which demonstrate strong association with Central Corneal Thickness (CCT). CCT is a risk factor of glaucoma, the most common cause of irreversible blindness worldwide…
Haitian Doctors’ Struggle To Restore Eye Care Is Aided By American Academy Of Ophthalmology Donations And Task Force Volunteers
At the American Academy of Ophthalmology’s (Academy) recent international meeting in Chicago, the Task Force on Haiti Recovery (Task Force) received donations of ophthalmic equipment, supplies, and educational materials valued at nearly $16,000 US dol…
UK Medical Student Ophthalmology Teaching Falling Short
UK medical schools are failing to comply with the recommended curriculum for ophthalmology, set out by the International Council of Ophthalmologists (ICO), suggests a survey published online in the British Journal of Ophthalmology…
Lazy Eye Appears To Respond Well To Acupuncture In Many Cases
Acupuncture may eventually become another optional treatment apart from patching for lazy eye, also known as amblyopia, especially among older children who have a poorer response to patching, say researchers from China in Archives of Ophthalmology. App…
Elsevier Enables Its E-Books To Read Aloud, Increasing Access For People With Print Disabilities
Elsevier, the world-leading publisher of scientific, technical and medical information products and solutions, has announced that it has enabled the text-to-speech option on all of its ePub book titles. The text-to-speech function enables an e-book to …
Three-Day Meeting On Eliminating River Blindness Kicks Off In Nigeria
A three-day meeting of the WHO African Program for Onchocerciasis (River blindness) Control (WHO/APOC) opened in Abuja, Nigeria, on Tuesday, PANA/Afrique en ligne reports (12/8)…
Vision And Safety Experts Release Paper On Protecting Eyes In The Workplace
Each day nearly 2,000 American workers suffer from avoidable workplace eye injuries that require medical treatment. Despite the risk of eye injury, many workers bypass appropriate precautions to protect their eyes…
Melanopsin Looks On The Bright Side Of Life
Better known as the light sensor that sets the body’s biological clock, melanopsin also plays an important role in vision: Via its messengers-so-called melanopsin-expressing retinal ganglion cells, or mRGCs-it forwards information about the brightness …
Looking On The Bright Side Of Life With Melanopsin
Better known as the light sensor that sets the body’s biological clock, melanopsin also plays an important role in vision: Via its messengers-so-called melanopsin-expressing retinal ganglion cells, or mRGCs-it forwards information about the brightness …
NICE’s Report On The Feasibility Of Appraising The Use Of Bevacizumab (Avastin) To Treat Eye Conditions
NICE has published its findings after exploring the feasibility of advising the NHS on the clinical and cost effectiveness of bevacizumab (Avastin, Genentech/Roche) to treat wet age-related macular degeneration (AMD), the leading cause of blindness in …